An immunocytochemical-derived correlate for evaluating the bridging of heteromeric mu-delta opioid protomers by bivalent ligands

ACS Chemical Biology

Volumn 8, Issue 7, 2013, Pages 1412-1416

  Yekkirala, Ajay S ^a,b   Kalyuzhny, Alexander E ^c   Portoghese, Philip S ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Department of Pharmacology ^*  (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DN 20; MA 19; MDAN 16; MDAN 21; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE; UNCLASSIFIED DRUG;

ANTINOCICEPTION; ARTICLE; CALCIUM TRANSPORT; CELL STRAIN HEK293; CELL TRACKING; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMOBILIZATION; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; INTERNALIZATION; PHARMACOPHORE; PRIORITY JOURNAL;

HEK293 CELLS; HUMANS; IMMOBILIZED NUCLEIC ACIDS; IMMUNOHISTOCHEMISTRY; LIGANDS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; NALTREXONE; PROMOTER REGIONS, GENETIC; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 84880166368     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400113d     Document Type: Article

References (30)

1. Cox, B. M., Borsodi, A., Caló, G., Chavkin, C., Christie, M. J., Civelli, O., Devi, L. A., Evans, C., Henderson, G., Höllt, V., Kieffer, B., Kitchen, I., Kreek, M., Liu-Chen, L., Meunier, J., Portoghese, P. S., Shippenberg, T. S., Simon, E. J., Toll, L., Traynor, J. R., Ueda, H., and Wong, Y. W. Opioid receptors. Last modified on 13/03/2013. Accessed on 13/05/2013. IUPHAR database (IUPHAR-DB), http://www.iuphar-db.org/DATABASE/ FamilyMenuForward?familyId=50.
2. Gutstein, H. and Akil, H. (2006) Opioid analgesics, in Goodman and Gilman's Pharmacological Basis of Therapeutics, The McGraw Hill Companies, Inc., New York.
3. Abdelhamid, E. E., Sultana, M., Portoghese, P. S., and Takemori, A. E. (1991) Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice J. Pharmacol. Exp. Ther. 258, 299-303
4. Kest, B., Lee, C. E., McLemore, G. L., and Inturrisi, C. E. (1996) An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice Brain Res. Bull. 39, 185-8
5. Sanchez-Blazquez, P., Garcia-Espana, A., and Garzon, J. (1997) Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors J. Pharmacol. Exp. Ther. 280, 1423-31
6. Nitsche, J. F., Schuller, A. G., King, M. A., Zengh, M., Pasternak, G. W., and Pintar, J. E. (2002) Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knock-out mice J. Neurosci. 22, 10906-10913
7. Portoghese, P. S., Sultana, M., and Takemori, A. E. (1988) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist Eur. J. Pharmacol. 146, 185-186
8. Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., and Devi, L. A. (2000) Heterodimerization of mu and delta opioid receptors: A role in opiate synergy J. Neurosci. 20, RC110
9. George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., and O'Dowd, B. F. (2000) Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties J. Biol. Chem. 275, 26128-26135
10. Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P. Y., Roerig, S. C., and Portoghese, P. S. (2005) Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series Proc. Nat. Acad. Sci. U.S.A. 102, 19208-19213
11. Portoghese, P. S. (2001) From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes J. Med. Chem. 44, 2259-2269
12. Portoghese, P. S., Ronsisvalle, G., Larson, D. L., Yim, C. B., Sayre, L. M., and Takemori, A. E. (1982) Opioid agonist and antagonist bivalent ligands as receptor probes Life Sci. 31, 1283-1286
13. Portoghese, P. S., Larson, D. L., Yim, C. B., Sayre, L. M., Ronsisvalle, G., Lipkowski, A. W., Takemori, A. E., Rice, K. C., and Tam, S. W. (1985) Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors J. Med. Chem. 28, 1140
14. Portoghese, P. S., Larson, D. L., Yim, C. B., Sayre, L. M., Ronsisvalle, G., Tam, S. W., and Takemori, A. E. (1986) Opioid agonist and antagonist bivalent ligands. The relationship of spacer length and selectivity at multiple opioid receptors J. Med. Chem. 29, 1855
15. 2 phenotypes. Selective targeting of delta-kappa heterodimers J. Med. Chem. 47, 2969-2972
16. Daniels, D. J., Kulkarni, A., Xie, Z., Bhushan, R. G., and Portoghese, P. S. (2005) A bivalent ligand (KDAN-18) containing δ-antagonist and κ-agonist pharmacophores bridges δ2 and κ1 opioid receptor phenotypes J. Med. Chem. 48, 1713-1716
17. Zhang, S., Yekkirala, A., Tang, Y., and Portoghese, P. S. (2009) A bivalent ligand (KMN-21) antagonist for μ/κ heterodimeric opioid receptors Bioorg. Med. Chem. Lett. 19, 6978-6980
18. Zheng, Y., Akgün, E., Harikumar, K. G., Hopson, J., Powers, M. D., Lunzer, M. M., Miller, L. J., and Portoghese, P. S. (2009) Association of μ opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands J. Med. Chem. 52, 247-258
19. Manglik, A., Kruse, A. C., Andrew, C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., and Granier, S. (2012) Crystal structure of the mu opioid receptor bound to a morphinan antagonist Nature 485, 321-326
20. Lenard, N. R., Daniels, D. J., Portoghese, P. S., and Roerig, S. C. (2007) Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores Eur. J. Pharmacol. 566, 75-82
21. Wang, D., Sun, X., Bohn, L. M., and Sadee, W. (2005) Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer Mol. Pharmacol. 67, 2173-2184
22. Hasbi, A., Nguyen, T., Fan, T., Cheng, R., Rashid, A., Alijaniaram, M., Rasenick, M. M., O'Dowd, B. F., and George, S. R. (2007) Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists Biochemistry 46, 12997-13009
23. Kostenis, E. (2001) Is G alpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors? Trends Pharmacol. Sci. 22, 560-564
24. Martini, L. and Whistler, J. L. (2007) The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence Curr. Opin. Neurobiol. 17, 556-64
25. Koch, T. and Hollt, V. (2008) Role of receptor internalization in opioid tolerance and dependence Pharmacol. Ther. 117, 199-206
26. von Zastrow, M. (2010) Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications Drug Alcohol Depen.d 108, 166-71
27. Kim, J. A., Bartlett, S., He, L., Nielsen, C. K., Chang, A. M., Kharazia, V., Waldhoer, M., Ou, C. J., Taylor, S., Ferwerda, M., Cado, D., and Whistler, J. L. (2008) Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence Curr. Biol. 18, 129-35
28. Charlton, J. J., Allen, P. B., Psifogeorgou, K., Chakravarty, S., Gomes, I., Neve, R. L., Devi, L. A., Greengard, P., Nestler, E. J., and Zachariou, V. (2008) Multiple actions of spinophilin regulate mu opioid receptor function Neuron 58, 238-47
29. Pradhan, A. A., Becker, J. A., Scherrer, G., Tryoen-Toth, P., Filliol, D., Matifas, A., Massotte, D., Gaveriaux-Ruff, C., and Kieffer, B. L. (2009) In vivo delta opioid receptor internalization controls behavioral effects of agonists PLoS One 4, e5425
30. Yekkirala, A. S., Kalyuzhny, A. E., and Portoghese, P. S. (2010) Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [D-Ala2-MePhe4-Glyol5]enkephalin as selective μ-∂ agonists ACS Chem. Neurosci. 1, 146-154